Multi-site Left Ventricular (MSLV) Pacing With Quartet 1458Q Lead

Abbott Medical Devices10 个研究点分布在 2 个国家目标入组 61 人开始时间: 2010年2月最近更新: 2019年2月4日

适应症

试验速览

The purpose of this clinical investigation is to evaluate the safety and hemodynamic performance of the MSLV Pacing feature in a clinical setting.

To evaluate the hemodynamic impact of different pacing MSLV configurations.

•Patients who have a recognised indication to receive a CRT-D device or an upgrade from a pacemaker or ICD to a CRT-D system.
•Patients have signed an informed consent form indicating their willingness to participate to this study.

•Patients who are unable to comply with the follow-up schedule based on their geographic location or for any reason.
•Patients with second or third degree AV Block
•Patients with intrinsic atrial rhythm < 40 bpm
•Patients with a previously implanted left ventricular pacing lead.
•Patients who are pregnant.
•Patients currently participating in a clinical investigation that includes an active treatment arm.
•Patients under 18 years of age.
•Patients with a life expectancy of less then 6 months.

发起方

申办方类型

Industry

责任方

Sponsor

Loading locations...